Aromatase inhibitors (AIs) are a class of medication used primarily in the treatment of hormone receptor-positive breast cancer in postmenopausal women. They work by blocking the aromatase enzyme, which plays a crucial role in the conversion of androgens to estrogens, thereby reducing estrogen levels in the body. This is significant because high levels of estrogen can fuel the growth of certain breast cancers.
https://madwave.club-nagelibre.fr/2026/09/22/understanding-aromatase-inhibitors-dosage/
1. Common Aromatase Inhibitors
The most commonly prescribed aromatase inhibitors include:
- Letrozole (Femara)
- Anastrozole (Arimidex)
- Exemestane (Aromasin)
2. Dosage Guidelines
Each aromatase inhibitor has its specific dosage recommendations, generally based on clinical studies. Below are the typical dosages:
- Letrozole: The standard dosage is 2.5 mg once daily.
- Anastrozole: The recommended dosage is 1 mg once daily.
- Exemestane: The usual dosage is 25 mg once daily.
3. Administration
Aromatase inhibitors can be taken with or without food. Consistency is key; hence, it’s recommended to take the medication at the same time each day. The pills should be swallowed whole with water.
4. Duration of Treatment
The duration of treatment with aromatase inhibitors typically varies, but common practice suggests a course of 5 years after surgery, depending on the individual patient’s risk assessment. It is essential to follow the healthcare provider’s recommendations regarding the length of treatment.
5. Side Effects and Considerations
While aromatase inhibitors are effective, they may cause side effects such as:
- Joint pain or stiffness
- Hot flashes
- Fatigue
- Bone density loss
Patients should report any severe side effects to their healthcare provider immediately. Regular monitoring through bone density tests may also be necessary, especially for those with pre-existing conditions that could lead to osteoporosis.
6. Conclusion
Understanding the correct dosage and administration of aromatase inhibitors is crucial for their effectiveness in treating hormone receptor-positive breast cancer. Patients should have open communication with their healthcare providers to ensure they are on the appropriate dosage and to manage any side effects.
